United States · Bill · HR
H.R. 4614 (107th)
To permit commercial importation of prescription drugs from Canada, and for other purposes.
Introduced
25 April 2002
Last action
6 May 2002 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Sen. Sanders, Bernard [I-VT], Rep. DeLauro, Rosa L. [D-CT-3], Rep. Hinchey, Maurice D. [D-NY-22], Rep. Kucinich, Dennis J. [D-OH-10], Rep. DeFazio, Peter A. [D-OR-4], Rep. Nadler, Jerrold [D-NY-12], Rep. Lee, Barbara [D-CA-12], Rep. Crowley, Joseph [D-NY-14], Rep. Conyers, John, Jr. [D-MI-13], Rep. McGovern, James P. [D-MA-2], Rep. Wynn, Albert Russell [D-MD-4], Rep. Napolitano, Grace F. [D-CA-32], Rep. Hilliard, Earl F. [D-AL-7], Rep. Brown, Corrine [D-FL-5], Rep. Olver, John W. [D-MA-1], Rep. Baldacci, John Elias [D-ME-2], Rep. Rivers, Lynn N. [D-MI-13], Rep. Frank, Barney [D-MA-4], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Carson, Julia [D-IN-7], Rep. Murtha, John P. [D-PA-12], Rep. Kleczka, Gerald D. [D-WI-4], Rep. Paul, Ron [R-TX-14], Rep. Bonior, David E. [D-MI-10], Rep. Pallone, Frank [D-NJ-6], Rep. Filner, Bob [D-CA-51], Rep. Bishop, Sanford D. [D-GA-2], Rep. Holden, Tim [D-PA-17], Rep. Serrano, Jose E. [D-NY-15], Rep. Barrett, Thomas M. [D-WI-5], Rep. McKinney, Cynthia A. [D-GA-4], Rep. Pomeroy, Earl [D-ND-At Large], Rep. LaFalce, John J. [D-NY-29], Rep. Jones, Stephanie Tubbs [D-OH-11], Rep. McDermott, Jim [D-WA-7], Rep. Oberstar, James L. [D-MN-8], Rep. Clay, Wm. Lacy [D-MO-1], Rep. Evans, Lane [D-IL-17], Rep. Tierney, John F. [D-MA-6], Rep. Costello, Jerry F. [D-IL-12], Rep. Slaughter, Louise McIntosh [D-NY-25], Rep. Woolsey, Lynn C. [D-CA-6], Sen. Brown, Sherrod [D-OH], Rep. Waters, Maxine [D-CA-43], Rep. Shows, Ronnie [D-MS-4], Rep. Stark, Fortney Pete [D-CA-13], Rep. Wexler, Robert [D-FL-19], Rep. Clement, Bob [D-TN-5]
Subjects
Healthcare
Source updated
2 January 2025
Summary
Amends provisions of the Federal Food, Drug, and Cosmetic Act set forth in the Medicine Equity and Drug Safety Act of 2000 to: (1) direct the Secretary of Health and Human Services to promulgate regulations permitting pharmacists and wholesalers to import Food and Drug Administration (FDA)-approved prescription drugs from Canada (currently, from Australia, Canada, Israel, Japan, New Zealand, Switzerland, South Africa, the countries in the European Union and the European Free Trade Association, or other countries designated by the Secretary); and (2) exclude an infused or intravenously injected drug or a drug that is inhaled during surgery. Prohibits discrimination in the sale of prescription drugs by manufacturers to pharmacists or wholesalers, requiring: (1) terms as favorable as those provided to foreign purchasers; and (2) full access to drugs permitted to be imported. Continues the requirement that exported donated prescription drugs may only be reimported by the manufacturer. Permits the Secretary to waive the prohibition against importing a prescription drug or device on a case-by-case basis, particularly those from Canada that are FDA-approved and for limited personal use. Requires a study and report by the: (1) Institute of Medicine of the National Academy of Sciences on the regulatory compliance of importers of drugs; and (2) Comptroller General on how drug prices were affected.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
25 April 2002
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
25 April 2002
Introduced
Introduced in House
Source: IntroReferral
25 April 2002
Introduced
Introduced in House
Source: IntroReferral
6 May 2002
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 25 April 2002 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 25 April 2002
Introduced in House (PDF)
Introduced in House · EN · 25 April 2002
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 25 April 2002
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Sanders, Bernard [I-VT] · I · Sponsor
- Rep. DeLauro, Rosa L. [D-CT-3] · D · Cosponsor
- Rep. Hinchey, Maurice D. [D-NY-22] · D · Cosponsor
- Rep. Kucinich, Dennis J. [D-OH-10] · D · Cosponsor
- Rep. DeFazio, Peter A. [D-OR-4] · D · Cosponsor
- Rep. Nadler, Jerrold [D-NY-12] · D · Cosponsor
- Rep. Lee, Barbara [D-CA-12] · D · Cosponsor
- Rep. Crowley, Joseph [D-NY-14] · D · Cosponsor
- Rep. Conyers, John, Jr. [D-MI-13] · D · Cosponsor
- Rep. McGovern, James P. [D-MA-2] · D · Cosponsor
- Rep. Wynn, Albert Russell [D-MD-4] · D · Cosponsor
- Rep. Napolitano, Grace F. [D-CA-32] · D · Cosponsor
- Rep. Hilliard, Earl F. [D-AL-7] · D · Cosponsor
- Rep. Brown, Corrine [D-FL-5] · D · Cosponsor
- Rep. Olver, John W. [D-MA-1] · D · Cosponsor
- Rep. Baldacci, John Elias [D-ME-2] · D · Cosponsor
- Rep. Rivers, Lynn N. [D-MI-13] · D · Cosponsor
- Rep. Frank, Barney [D-MA-4] · D · Cosponsor
- Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Cosponsor
- Rep. Carson, Julia [D-IN-7] · D · Cosponsor
- Rep. Murtha, John P. [D-PA-12] · D · Cosponsor
- Rep. Kleczka, Gerald D. [D-WI-4] · D · Cosponsor
- Rep. Paul, Ron [R-TX-14] · R · Cosponsor
- Rep. Bonior, David E. [D-MI-10] · D · Cosponsor
- Rep. Pallone, Frank [D-NJ-6] · D · Cosponsor
- Rep. Filner, Bob [D-CA-51] · D · Cosponsor
- Rep. Bishop, Sanford D. [D-GA-2] · D · Cosponsor
- Rep. Holden, Tim [D-PA-17] · D · Cosponsor
- Rep. Serrano, Jose E. [D-NY-15] · D · Cosponsor
- Rep. Barrett, Thomas M. [D-WI-5] · D · Cosponsor
- Rep. McKinney, Cynthia A. [D-GA-4] · D · Cosponsor
- Rep. Pomeroy, Earl [D-ND-At Large] · D · Cosponsor
- Rep. LaFalce, John J. [D-NY-29] · D · Cosponsor
- Rep. Jones, Stephanie Tubbs [D-OH-11] · D · Cosponsor
- Rep. McDermott, Jim [D-WA-7] · D · Cosponsor
- Rep. Oberstar, James L. [D-MN-8] · D · Cosponsor
- Rep. Clay, Wm. Lacy [D-MO-1] · D · Cosponsor
- Rep. Evans, Lane [D-IL-17] · D · Cosponsor
- Rep. Tierney, John F. [D-MA-6] · D · Cosponsor
- Rep. Costello, Jerry F. [D-IL-12] · D · Cosponsor
- Rep. Slaughter, Louise McIntosh [D-NY-25] · D · Cosponsor
- Rep. Woolsey, Lynn C. [D-CA-6] · D · Cosponsor
- Sen. Brown, Sherrod [D-OH] · D · Cosponsor
- Rep. Waters, Maxine [D-CA-43] · D · Cosponsor
- Rep. Shows, Ronnie [D-MS-4] · D · Cosponsor
- Rep. Stark, Fortney Pete [D-CA-13] · D · Cosponsor
- Rep. Wexler, Robert [D-FL-19] · D · Cosponsor
- Rep. Clement, Bob [D-TN-5] · D · Cosponsor
Showing 48 of 58 sponsors and actors.
Related records
- related to ← Prescription Drug Price Parity for Americans Act
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/107th-congress/house-bill/4614
- Open data entity: https://api.congress.gov/v3/bill/107/hr/4614
- us · 107-hr-4614 · source updated 2 January 2025